Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection
The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
Simulated Moving Bed (SMB) technology is a highly engineered process for implementing chromatographic separation
The company plans to expand their capacity to meet the needs of pharma and biotech industries
_256_384.jpg)
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
The NFI is published to promote the rational use of medicines in the country.
First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders
Conventional Itraconazole mainstay drug to fight fungal infection has high result variance and low patient compliance because of dosing dependence upon food, acidic beverage and antacid consumption
The kit preserves viral nucleic acids in a non-hazardous stabilization solution that inactivates common respiratory viruses for safer sample collection
Subscribe To Our Newsletter & Stay Updated
